CSF2 and neoplasm: This combination sought to improve antitumor effects by inducing virus-mediated tumor cell death and release of tumor antigens, as well as recruiting/maturing/activating antigen-presenting cells through GM-CSF induction while blocking/depleting Tregs via anti-CTLA-4.